HRO

Harrow

HROW • NASDAQ • Stock Fundamentals

Harrow is a medical - pharmaceuticals company in the healthcare sector trading on NASDAQ, led by CEO Mark L. Baum, with a market cap of $1.3B.

Market Cap$1.3B
Employees382.0
CEOMark L. Baum
CountryUnited States of America
Healthcare
Medical - Pharmaceuticals
Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026
View report
Next EarningsAug 10, 2026 · in 2 monthsAfter Market Close · Q2 2026
Income StatementBalance SheetCash FlowSegments

Financials

Based on Q1 2026 filing

View all metrics
HRO

Harrow FAQ

Common questions about Harrow

Harrow (HROW) has a market capitalization of $1.3B and trades on NASDAQ.

Harrow has approximately 382 employees.